DK3351546T3 - Langtidsvirkende injicerbare moxidectinformuleringer - Google Patents

Langtidsvirkende injicerbare moxidectinformuleringer Download PDF

Info

Publication number
DK3351546T3
DK3351546T3 DK17190708.2T DK17190708T DK3351546T3 DK 3351546 T3 DK3351546 T3 DK 3351546T3 DK 17190708 T DK17190708 T DK 17190708T DK 3351546 T3 DK3351546 T3 DK 3351546T3
Authority
DK
Denmark
Prior art keywords
moxidect
informulations
long
acting injectable
injectable
Prior art date
Application number
DK17190708.2T
Other languages
English (en)
Other versions
DK3351546T5 (da
Inventor
Susan Mancini Cady
Baoqing Ma
Robert Clark Chapman
Chunhua Yang
Uday Jain
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Application granted granted Critical
Publication of DK3351546T3 publication Critical patent/DK3351546T3/da
Publication of DK3351546T5 publication Critical patent/DK3351546T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK17190708.2T 2011-12-02 2012-11-30 Langtidsvirkende injicerbare moxidectinformuleringer DK3351546T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161566336P 2011-12-02 2011-12-02
EP12798570.3A EP2785719B1 (en) 2011-12-02 2012-11-30 Long-acting injectable moxidectin formulations and novel moxidectin crystal forms

Publications (2)

Publication Number Publication Date
DK3351546T3 true DK3351546T3 (da) 2024-04-29
DK3351546T5 DK3351546T5 (da) 2024-08-12

Family

ID=47324470

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17190708.2T DK3351546T5 (da) 2011-12-02 2012-11-30 Langtidsvirkende injicerbare moxidectinformuleringer
DK12798570.3T DK2785719T3 (da) 2011-12-02 2012-11-30 Langtidsvirkende injicerbare moxidectin-formuleringer og hidtil ukendte moxidectin-krystalformer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12798570.3T DK2785719T3 (da) 2011-12-02 2012-11-30 Langtidsvirkende injicerbare moxidectin-formuleringer og hidtil ukendte moxidectin-krystalformer

Country Status (15)

Country Link
US (2) US8715711B2 (da)
EP (2) EP3351546B9 (da)
CN (2) CN105232529B (da)
AU (4) AU2012345813B2 (da)
BR (2) BR112014013371B1 (da)
CA (2) CA2857958C (da)
DK (2) DK3351546T5 (da)
ES (2) ES2978407T3 (da)
HK (2) HK1201264A1 (da)
HU (1) HUE036441T2 (da)
MX (1) MX358476B (da)
PL (2) PL2785719T3 (da)
PT (2) PT3351546T (da)
WO (1) WO2013082373A1 (da)
ZA (1) ZA201404122B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015025875B1 (pt) * 2013-04-12 2021-06-29 Zoetis Services Llc Composição injetável estável para o tratamento de uma infecção endoparasitária por helmintos em animais não humanos, composição para o tratamento de uma infecção ou infestação endoparasitária por helmintos em um animal não humano, e uso de doramectina e levamisol, ou um sal farmaceuticamente aceitável do mesmo
CN103405388B (zh) * 2013-08-21 2015-04-08 成都乾坤动物药业有限公司 一种可湿性莫西菌素固体分散粉及其制备方法和用途
FR3028314B1 (fr) * 2014-11-07 2016-12-23 Aircelle Sa Procede de caracterisation du vieillissement thermique de materiaux composites, en particulier de materiaux composites a matrice organique
KR102593069B1 (ko) * 2015-04-08 2023-10-23 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 이속사졸린 활성제를 포함하는 서방형 주사 제형, 이의 방법 및 용도
MX2019006742A (es) 2016-12-09 2019-09-05 Bayer Animal Health Gmbh Preparacion farmaceutica y metodo para su fabricacion.
US11318156B2 (en) * 2017-04-13 2022-05-03 Ceva Sante Animale Solid injectable veterinary implants comprising monocyclic lactone
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
BR112020010291A2 (pt) * 2017-11-23 2020-11-17 Ceva Sante Animale composição contendo moxidectina para tratamento de infestações de parasitas
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
CH604517A5 (da) 1976-08-19 1978-09-15 Ciba Geigy Ag
US5089490A (en) 1977-04-02 1992-02-18 Hoechst Aktiengesellschaft Cephem derivatives
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4457920A (en) 1981-09-03 1984-07-03 Merck & Co., Inc. 4a-Substituted avermectin compounds
US4423209A (en) 1982-02-26 1983-12-27 Merck & Co., Inc. Processes for the interconversion of avermectin compounds
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
DE3235931A1 (de) 1982-09-29 1984-03-29 Bayer Ag, 5090 Leverkusen Koeder zur bekaempfung von ungeziefer
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
US5106994A (en) 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
EP0165900A3 (de) 1984-06-08 1986-05-28 Ciba-Geigy Ag Neue Lactone, Verfahren zu ihrer Herstellung und ihre Verwendung in der Schädlingsbekämpfung
IL76708A (en) 1984-10-18 1990-01-18 Ciba Geigy Ag Substituted n-benzoyl-n'-(2,5-dichloro-4(1,1,2,3,3,3-hexafluoropropyloxy)-phenyl)ureas,their preparation and pesticidal compositions containing them
ATE67493T1 (de) 1985-02-04 1991-10-15 Bayer Agrochem Kk Heterocyclische verbindungen.
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
AR243191A1 (es) 1986-03-25 1993-07-30 Sankyo Co Procedimiento para preparar compuestos de macrolida
CA1296329C (en) 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
ATE75745T1 (de) 1986-07-02 1992-05-15 Ciba Geigy Ag Pestizide.
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US4831016A (en) 1986-10-31 1989-05-16 Merck & Co., Inc. Reduced avermectin derivatives
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4806527A (en) 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (de) 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
US4895837A (en) 1988-01-29 1990-01-23 Merck & Co., Inc. Avermectin derivatives
US4873224A (en) 1988-05-23 1989-10-10 Merck & Co., Inc. Avermectin derivatives
US4906619A (en) 1988-07-22 1990-03-06 Merck & Co., Inc. Alkyl avermectin derivatives
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5030622A (en) 1989-06-02 1991-07-09 Merck & Co., Inc. Avermectin derivatives
US5057499A (en) 1989-06-02 1991-10-15 Merck & Co. Inc. Avermectin derivatives
US5023241A (en) 1989-07-31 1991-06-11 Merck & Co., Inc. Avermectin derivatives
US4988824A (en) 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds
US5830875A (en) 1989-10-30 1998-11-03 Merck & Co., Inc. 24-and 25-substituted avermectin and milbemycin derivatives
US5055454A (en) 1989-10-30 1991-10-08 Merck & Co., Inc. 13-epi-avermectin derivatives useful as antiparasitic agents
IE904606A1 (en) 1989-12-21 1991-07-03 Beecham Group Plc Novel products
US5169839A (en) 1990-05-11 1992-12-08 Merck & Co., Inc. Derivatives of 3'- and 3"-o-desmethyl avermectin compounds, compositions and methods of treating melmintic and parasitic infections
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5208222A (en) 1991-03-28 1993-05-04 Merck & Co., Inc. 4"-and 4'-alkylthio avermectin derivatives
WO1992022555A1 (en) 1991-06-17 1992-12-23 Beecham Group Plc Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
US5262400A (en) 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US5244879A (en) 1992-03-18 1993-09-14 Merck & Co., Inc. 23-nor-23-oxa avermectin analogs are active anthelmintic agents
US5162363A (en) 1992-03-18 1992-11-10 Merck & Co., Inc. 23-nor-23-thia avermectin analogs are active anthelmintic agents
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
TW334436B (en) 1995-07-21 1998-06-21 Upjohn Co Antiparasitic marcfortines and paraherquamides
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US5885607A (en) 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
FR2752525B1 (fr) 1996-08-20 2000-05-05 Rhone Merieux Procede de lutte contre les myiases des cheptels bovins et ovins et compositions pour la mise en oeuvre de ce procede
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
FR2750861B1 (fr) 1996-07-11 1998-12-24 Rhone Merieux Procedes d'elimination des parasites, et notamment des ectoparasites de vertebres, notamment de mammiferes et compositions pour la mise en oeuvre de ce procede
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
US6733767B2 (en) 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
DE60116615T2 (de) 2000-04-27 2006-09-07 Sankyo Lifetech Co.Ltd. 13-substituierte milbemycinderivate, ihre herstellung und ihre verwendung gegen insekten und andere schadorganismen
US6399786B1 (en) 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
AU2001278694A1 (en) 2000-08-09 2002-02-18 The Kitasato Institute Avermectin derivatives
AUPR602501A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
TW200409760A (en) 2002-09-11 2004-06-16 Novartis Ag Organic compounds
US7326428B2 (en) 2002-12-18 2008-02-05 Evergreen Innovation Partners I, Lp Multi-compartment container and lid assembly
US7348417B2 (en) 2003-08-07 2008-03-25 Wyeth Method of purifying moxidectin through crystallization
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
DK1731512T3 (da) 2004-03-05 2015-01-05 Nissan Chemical Ind Ltd Isoxazolin-substitueret benzamidforbindelse og middel til bekæmpelse af skadelige organismer
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
WO2007070606A2 (en) 2005-12-14 2007-06-21 E. I. Du Pont De Nemours And Company Isoxazolines for controlling invertebrate pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
MY146638A (en) 2007-04-10 2012-09-14 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
RS58416B1 (sr) 2007-05-15 2019-04-30 Merial Inc Ariloazol-2-il cijanoetilamino jedinjenja, postupci dobijanja i postupci njihove primene
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX368680B (es) 2007-06-27 2019-10-11 Du Pont Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga.
AU2008272646B2 (en) 2007-06-29 2013-08-22 Zoetis Services Llc Anthelmintic combination
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用

Also Published As

Publication number Publication date
ES2659159T3 (es) 2018-03-14
EP3351546B9 (en) 2024-07-10
DK3351546T5 (da) 2024-08-12
CA2857958A1 (en) 2013-06-06
AU2012345813B2 (en) 2017-02-02
US8715711B2 (en) 2014-05-06
EP2785719B1 (en) 2017-11-08
AU2012345813A1 (en) 2014-07-03
EP2785719A1 (en) 2014-10-08
AU2017200177A1 (en) 2017-02-02
BR122020002199B1 (pt) 2021-01-19
US20140323559A1 (en) 2014-10-30
MX358476B (es) 2018-08-22
HK1201264A1 (en) 2015-08-28
PL3351546T3 (pl) 2024-09-09
NZ626149A (en) 2016-06-24
CA2857958C (en) 2020-08-25
BR112014013371A2 (pt) 2017-06-13
PL2785719T3 (pl) 2018-03-30
CN105232529B (zh) 2018-11-23
ES2978407T3 (es) 2024-09-12
HUE036441T2 (hu) 2018-07-30
PT3351546T (pt) 2024-03-07
AU2019229407A1 (en) 2019-10-03
CN104053660A (zh) 2014-09-17
ZA201404122B (en) 2015-09-30
CN104053660B (zh) 2016-12-28
US9044453B2 (en) 2015-06-02
CA3082432A1 (en) 2013-06-06
PT2785719T (pt) 2018-02-08
CA3082432C (en) 2023-01-03
AU2017268548B2 (en) 2019-09-19
AU2017200177B2 (en) 2017-11-23
AU2017268548A1 (en) 2018-01-04
HK1256641A1 (zh) 2019-09-27
EP3351546B1 (en) 2024-02-14
EP3351546A1 (en) 2018-07-25
DK2785719T3 (da) 2017-12-04
MX2014006601A (es) 2015-03-05
US20130143956A1 (en) 2013-06-06
WO2013082373A1 (en) 2013-06-06
BR112014013371B1 (pt) 2020-04-07
CN105232529A (zh) 2016-01-13

Similar Documents

Publication Publication Date Title
NO2021037I1 (no) evinakumab
DK2744810T4 (da) Tenofovir-alafenamid-hemifumarat
BR112013020613A2 (pt) autoinjetor
DK2769050T3 (da) Propsensor
DK3384944T3 (da) Autoinjektor
DK2841054T3 (da) Injicerbart præparat
BR112014000879A2 (pt) deflegmador
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
DK3351546T3 (da) Langtidsvirkende injicerbare moxidectinformuleringer
DE102011100082A8 (de) Traygreifvorrichtung
DK3141251T3 (da) Koloskopi - forberedelse
DE112011104936A5 (de) Stanzstauchniet
DE112012000958A5 (de) Handsäge
DK2476953T3 (da) Fluidbedkedel
DE112012002458A5 (de) Hydrotransformator
DE112012000819A5 (de) Gurtbandfänger
DE112012005313A5 (de) Leuchtbild
DK2526750T3 (da) Høbjærgningsmaskine
DE112012001294T8 (de) Umspritzungsverfahren
ES2404690B1 (es) Quitanieves avanzado
UA23002S (uk) Ніж
DE102011117169A8 (de) Absetzplattenanordnung
DE112011105396A5 (de) Nachverfestigungsverfahren
ES1074622Y (es) Pilona mejorada
DK2681057T3 (da) Nanofiber-mærkning